Search research articles
Contact Us
Filters
Showing results (81-90 of 182) with videos related to
Page
of 19
Sort By:
Oncotarget
|
February 11, 2016
Defining specificity and on-target activity of BH3-mimetics using engineered B-ALL cell lines
Brian Koss, Jeremy Ryan, Amit Budhraja, et al.
Cell
|
October 16, 2012
Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML
Thanh-Trang Vo, Jeremy Ryan, Ruben Carrasco, et al.
Breast Cancer Research : BCR
|
August 6, 2021
Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer
Jessica Castrillon Lal, Madeline G Townsend, Anita K Mehta, et al.
Blood
|
October 17, 2018
Targeted inhibition of PI3Kα/δ is synergistic with BCL-2 blockade in genetically defined subtypes of DLBCL
Kamil Bojarczuk, Kirsty Wienand, Jeremy A Ryan, et al.
Cancer Research
|
July 14, 2021
Cell Line-Specific Network Models of ER<sup>+</sup> Breast Cancer Identify Potential PI3Kα Inhibitor Resistance Mechanisms and Drug Combinations
Jorge Gómez Tejeda Zañudo, Pingping Mao, Clara Alcon, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 18, 2018
Iterative optimization yields Mcl-1-targeting stapled peptides with selective cytotoxicity to Mcl-1-dependent cancer cells
Raheleh Rezaei Araghi, Gregory H Bird, Jeremy A Ryan, et al.
The Journal of Clinical Investigation
|
September 7, 2016
Functionally identifiable apoptosis-insensitive subpopulations determine chemoresistance in acute myeloid leukemia
Patrick D Bhola, Brenton G Mar, R Coleman Lindsley, et al.
Leukemia
|
May 5, 2022
Author Correction: Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma
Sophia Adamia, Shruti Bhatt, Kenneth Wen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 2, 2021
Mitochondrial apoptotic priming is a key determinant of cell fate upon p53 restoration
Francisco J Sánchez-Rivera, Jeremy Ryan, Yadira M Soto-Feliciano, et al.
Cell Death and Differentiation
|
February 19, 2026
What does BCL-2 do? From new molecular insights to the clinical implications
Carlo M Croce, Stephen W G Tait, Ana J Garcia-Sáez, et al.
Page
of 19
Search research articles
Search
Showing results (81-90 of 182) with videos related to
Sort By:
Page
of 19
Oncotarget
|
February 11, 2016
Defining specificity and on-target activity of BH3-mimetics using engineered B-ALL cell lines
Brian Koss, Jeremy Ryan, Amit Budhraja, et al.
Cell
|
October 16, 2012
Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML
Thanh-Trang Vo, Jeremy Ryan, Ruben Carrasco, et al.
Breast Cancer Research : BCR
|
August 6, 2021
Comparing syngeneic and autochthonous models of breast cancer to identify tumor immune components that correlate with response to immunotherapy in breast cancer
Jessica Castrillon Lal, Madeline G Townsend, Anita K Mehta, et al.
Blood
|
October 17, 2018
Targeted inhibition of PI3Kα/δ is synergistic with BCL-2 blockade in genetically defined subtypes of DLBCL
Kamil Bojarczuk, Kirsty Wienand, Jeremy A Ryan, et al.
Cancer Research
|
July 14, 2021
Cell Line-Specific Network Models of ER<sup>+</sup> Breast Cancer Identify Potential PI3Kα Inhibitor Resistance Mechanisms and Drug Combinations
Jorge Gómez Tejeda Zañudo, Pingping Mao, Clara Alcon, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
January 18, 2018
Iterative optimization yields Mcl-1-targeting stapled peptides with selective cytotoxicity to Mcl-1-dependent cancer cells
Raheleh Rezaei Araghi, Gregory H Bird, Jeremy A Ryan, et al.
The Journal of Clinical Investigation
|
September 7, 2016
Functionally identifiable apoptosis-insensitive subpopulations determine chemoresistance in acute myeloid leukemia
Patrick D Bhola, Brenton G Mar, R Coleman Lindsley, et al.
Leukemia
|
May 5, 2022
Author Correction: Combination therapy targeting Erk1/2 and CDK4/6i in relapsed refractory multiple myeloma
Sophia Adamia, Shruti Bhatt, Kenneth Wen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
June 2, 2021
Mitochondrial apoptotic priming is a key determinant of cell fate upon p53 restoration
Francisco J Sánchez-Rivera, Jeremy Ryan, Yadira M Soto-Feliciano, et al.
Cell Death and Differentiation
|
February 19, 2026
What does BCL-2 do? From new molecular insights to the clinical implications
Carlo M Croce, Stephen W G Tait, Ana J Garcia-Sáez, et al.
Page
of 19